Acute Leukemia | Medscape

Acute Leukemia News

Stem Cell Allografts Effective for High-Risk AML Subtype Hematopoietic stem cell transplants are more effective than other standard consolidation therapies for patients with monosomal karyotype acute myeloid leukemia.
Reuters Health Information, May 15, 2012
Deferasirox Reduces Iron Overload in Myelodysplastic Syndrome Deferasirox reduces serum ferritin and labile plasma iron in patients with myelodysplastic syndrome (MDS), according to a report online April 30th in the Journal of Clinical Oncology.
Reuters Health Information, May 11, 2012

Crossing Boundaries in Molecular Therapy: HER2 in ALL Looking at a recent report describing the use of trastuzumab in HER2-positive ALL, Dr. Maurie Markman considers what this means for the future of molecular-targeted cancer therapy.
Medscape Hematology-Oncology, May 15, 2012
Incredibly Shrinking Risk for Secondary AML Dr. Maurie Markman reports on a study indicating that risk for therapy-related AML in ovarian cancer patients has declined dramatically since the 1980s. Is it because of increased paclitaxel use?
Medscape Hematology-Oncology, January 6, 2012

Gemtuzumab Boosts Survival in AML
Medscape Hematology-Oncology, December 23, 2011
2011 Top Game Changers in Oncology
Medscape Hematology-Oncology, November 23, 2011
Pharmacogenomics of 6-Mercaptopurine: Clinical Implications
Medscape Genomic Medicine, November 1, 2011
One Patient, Two Blood Cancers: What Happened Here?
Medscape Hematology-Oncology, July 21, 2011

Features of Secondary Acute Promyelocytic Leukemia
American Journal of Clinical Pathology, April 26, 2012
Anthracycline Dose Intensification in Young Adults With AML
Therapeutic Advances in Hematology, March 15, 2012
Transplantation Conditioning in AML and Myelodysplastic Syndrome
Therapeutic Advances in Hematology, February 14, 2012
Parental Prenatal Smoking and Risk of Childhood ALL
American Journal of Epidemiology, January 23, 2012
Reduced Conditioning in Allogeneic Cell Transplantation for AML
Cancer Control: Journal of the Moffitt Cancer Center, December 1, 2011